Suppr超能文献

儿童使用益生菌相关的侵袭性感染:一项系统评价

Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review.

作者信息

D'Agostin Martina, Squillaci Domenica, Lazzerini Marzia, Barbi Egidio, Wijers Lotte, Da Lozzo Prisca

机构信息

Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.

Institute of Maternal and Child Health-IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137 Trieste, Italy.

出版信息

Children (Basel). 2021 Oct 16;8(10):924. doi: 10.3390/children8100924.

Abstract

Although the effectiveness of probiotics has only been proven in specific conditions, their use in children is massively widespread because of their perception as harmless products. Recent evidence raises concerns about probiotics' safety, especially but not only in the paediatric population due to severe opportunistic infections after their use. This review aimed at summarising available case reports on invasive infections related to probiotics' use in children. For this purpose, we assessed three electronic databases to identify papers describing paediatric patients with documented probiotic-derived invasive infections, with no language restrictions. A total of 49 case reports from 1995 to June 2021 were identified. The infections were caused by spp. (35%), spp. (29%), spp. (31%), (4%), and (2%). Most (80%) patients were younger than 2 years old and sepsis was the most observed condition (69.4%). All the patients except one had at least one condition facilitating the development of invasive infection, with prematurity (55%) and intravenous catheter use (51%) being the most frequent. Three (6%) children died. Given the large use of probiotics, further studies aiming at evaluating the real incidence of probiotic-associated systemic infections are warranted.

摘要

尽管益生菌的有效性仅在特定条件下得到证实,但由于它们被视为无害产品,在儿童中的使用非常广泛。最近的证据引发了对益生菌安全性的担忧,尤其是在儿科人群中,因为使用后会出现严重的机会性感染,但不仅限于此。本综述旨在总结关于儿童使用益生菌相关侵袭性感染的现有病例报告。为此,我们评估了三个电子数据库,以识别描述有记录的益生菌源性侵袭性感染儿科患者的论文,无语言限制。共识别出1995年至2021年6月的49例病例报告。感染由 菌属(35%)、 菌属(29%)、 菌属(31%)、 (4%)和 (2%)引起。大多数(80%)患者年龄小于2岁,败血症是最常见的情况(69.4%)。除一名患者外,所有患者至少有一种促进侵袭性感染发展的情况,早产(55%)和使用静脉导管(51%)最为常见。三名(6%)儿童死亡。鉴于益生菌的广泛使用,有必要进一步开展研究以评估益生菌相关全身感染的实际发生率。

相似文献

2
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2015 Dec 22(12):CD004827. doi: 10.1002/14651858.CD004827.pub4.
3
Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.益生菌预防儿童抗生素相关性腹泻
Explore (NY). 2016 Nov-Dec;12(6):463-466. doi: 10.1016/j.explore.2016.08.015. Epub 2016 Aug 26.
5
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2011 Nov 9(11):CD004827. doi: 10.1002/14651858.CD004827.pub3.
8
Safety of probiotics: translocation and infection.益生菌的安全性:易位与感染。
Nutr Rev. 2008 Apr;66(4):192-202. doi: 10.1111/j.1753-4887.2008.00024.x.

引用本文的文献

5
Probiotics and the Risk of Infection.益生菌与感染风险
Clin Perinatol. 2025 Mar;52(1):87-100. doi: 10.1016/j.clp.2024.10.006. Epub 2024 Nov 27.
6
The neonatal gut microbiome in health and disease.健康与疾病状态下的新生儿肠道微生物群
Gut Microbes. 2025 Dec;17(1):2457499. doi: 10.1080/19490976.2025.2457499. Epub 2025 Jan 27.

本文引用的文献

3
Probiotics for treating acute infectious diarrhoea.益生菌治疗急性感染性腹泻。
Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048. doi: 10.1002/14651858.CD003048.pub4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验